Chiesi Ventures is a venture capital firm that invests in companies providing services and treatment for rare and orphan disorders.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Chiesi Ventures is a venture capital firm that invests in companies providing services and treatment for rare and orphan disorders.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2021 | Glycomine | Series B | 0 |
8/2019 | Glycomine | Series B | 0 |
9/2018 | 4D Molecular Therapeutics | Series B | 0 |
4/2014 | Sentieon | Series A | 0 |
10/2018 | VelosBio | Series A | 58M |
3/2021 | Aura Biosciences | Venture Round | 0 |
9/2018 | Minoryx Therapeutics | Series B | 0 |
7/2017 | Kezar Life Sciences | Series B | 0 |
11/2016 | Glycomine | Series A | 0 |
4/2017 | Sentien Biotechnologies | Series A | 12M |
11/2018 | Mirum Pharmaceuticals | Series A | 120M |
10/2015 | Minoryx Therapeutics | Series A | 0 |
3/2015 | Aura Biosciences | Series B | 0 |
12/2020 | Reneo Pharmaceuticals | Series B | 0 |
6/2020 | 4D Molecular Therapeutics | Series C | 0 |
12/2017 | Aura Biosciences | Series C | 0 |
10/2018 | CuraSen Therapeutics | Series A | 54.5M |
6/2021 | Glycomine | Series B | 0 |
3/2021 | Aura Biosciences | Venture Round | 0 |
12/2020 | Reneo Pharmaceuticals | Series B | 0 |
6/2020 | 4D Molecular Therapeutics | Series C | 0 |
8/2019 | Glycomine | Series B | 0 |
11/2018 | Mirum Pharmaceuticals | Series A | 0 |
10/2018 | CuraSen Therapeutics | Series A | 0 |
10/2018 | VelosBio | Series A | 0 |
9/2018 | Minoryx Therapeutics | Series B | 0 |
9/2018 | 4D Molecular Therapeutics | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|